Heartware Ventricular Assist System Recall Issued Due to Injury, Death Risk

|

Federal health regulators indicate that a recall has been issued for the HeartWare Ventricular Assist System, due to a risk that it may fail and pose a risk of death for patients.  

This week the FDA warned that a HeartWare Ventricular Assist System recall issued in December should be considered a class 1 medical device recall, which is the most serious category. The classification came after the manufacturer indicated that the device may stop working when a patient needs it.

The HeartWare, also known as a ventricular assist device (VAD), is used as a bridge device on patients suffering from advanced heart failure while they await cardiac transplantation . It is used during emergency medical flights on airplanes and helicopters, as well as in hospitals, to keep patients alive until a heart transplant can be performed.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

According to the reports received by HeartWare, Inc., the driveline connector locking mechanism on the device may fail to engage on some units. As a result of this manufacturing defect, the device may fail and stop pumping, leading to serious injury or death of the patient.

The recall affects the HeartWare Ventricular Assist System with Catalog Numbers 1100, 1101, 1102, 1103, 1104, and 1205. Serial numbers of devices affected by the recall include HW001 to HW 11270 and HW20001 to HW 20296. The recalled devices were manufactured between March 6, 2006 and October 17, 2013. They were distributed between March 17, 2006, and November 29, 2013.

The company first warned customers on December 12, 2013, with an Urgent Medical Device Correction letter. However, now the FDA has determined it is a class 1 medical device recall, suggesting that continued use of the Heartware system poses a risk of serious adverse health outcomes or death. HeartWare has indicated that it will soon send out an updated letter to customers, alerting them to the recall status.

The FDA advises patients that if the driveline becomes disconnected from the patient controller, a “VAD Stopped” high priority alarm will sound, They should immediately reconnect the driveline to the controller as instructed by the patient manual and contact their doctor or VAD coordinator.

Doctors are advised to follow up visit with patients with the affected HVAD to inspect the driveline connector. They are also advised to inspect the connector for proper locking and to ensure that the assembly remains secure every time the device is implanted and at every routine visit.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended.
A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users.
The withdrawal of two Cartiva toe implant lawsuits has sparked rumors of a potential settlement agreement to resolve product liability claims over the recalled devices.